Literature DB >> 29398195

Does epiaortic ultrasound screening reduce perioperative stroke in patients undergoing coronary surgery? A topical review.

Asad Ikram1, Hafsa Mohiuddin2, Aisha Zia2, Hafiz Umair Siddiqui3, Hoda Javadikasgari3, Marijan Koprivanac4, Sajjad Raza5, Atif Zafar1.   

Abstract

Although the occurrence of stroke in patients undergoing coronary artery bypass grafting (CABG) is decreasing, it remains an important concern. Therefore, it is important to identify and adopt strategies that can decrease the incidence of stroke in these patients. One of the strategies that have demonstrated the potential to decrease the rate of post-CABG stroke is an assessment of aorta for atherosclerosis before surgery and changing the surgical plan accordingly to minimize the stroke risk. This assessment can be done through palpation of the aorta, transesophageal echocardiography (TEE), and epiaortic ultrasound scanning (EAS). EAS has shown superiority over both palpation and TEE for intraoperative evaluation of aorta. However, despite the evidence demonstrating reduced stroke rates with the EAS-guided approach, EAS is not yet the standard of care procedure in patients undergoing CABG. Therefore, we have reviewed the literature for evidence that supports the routine use of EAS in patients undergoing coronary surgery and have presented solutions to overcome the barriers to its routine use.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Coronary surgery; Epiaortic ultrasound; Perioperative stroke; Stroke risk reduction

Mesh:

Year:  2018        PMID: 29398195     DOI: 10.1016/j.jocn.2018.01.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

Review 1.  Stroke Rates Following Surgical Versus Percutaneous Revascularization for Ischemic Heart Disease.

Authors:  Jithendhar Kandimalla; Zain Hussain; Paisith Piriyawat; Gustavo Rodriguez; Alberto Maud; Rakesh Khatri; Salvador Cruz-Flores; Anantha R Vellipuram
Journal:  Curr Cardiol Rep       Date:  2021-03-15       Impact factor: 2.931

2.  Impact of Aortic Atherosclerosis Burden on Outcomes of Surgical Aortic Valve Replacement.

Authors:  Alexander Iribarne; Stephanie Pan; Jock N McCullough; Joseph P Mathew; Judy Hung; Xin Zeng; Pierre Voisine; Patrick T O'Gara; Nancy M Sledz; Annetine C Gelijns; Wendy C Taddei-Peters; Steven R Messé; Alan J Moskowitz; Vinod H Thourani; Michael Argenziano; Mark A Groh; Gennaro Giustino; Jessica R Overbey; J Michael DiMaio; Peter K Smith
Journal:  Ann Thorac Surg       Date:  2019-08-07       Impact factor: 4.330

3.  Epiaortic Ultrasound for Assessment of Intraluminal Atheroma; Insights from the REGROUP Trial.

Authors:  Alexander D Shapeton; Kay B Leissner; Suzana M Zorca; Houman Amirfarzan; Eileen M Stock; Kousick Biswas; Miguel Haime; Venkatesh Srinivasa; Jacquelyn A Quin; Marco A Zenati
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-11-09       Impact factor: 2.628

Review 4.  Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes.

Authors:  Mario Gaudino; Dominick J Angiolillo; Antonino Di Franco; Davide Capodanno; Faisal Bakaeen; Michael E Farkouh; Stephen E Fremes; David Holmes; Leonard N Girardi; Sunao Nakamura; Stuart J Head; Seung-Jung Park; Michael Mack; Patrick W Serruys; Marc Ruel; Gregg W Stone; Derrick Y Tam; Michael Vallely; David P Taggart
Journal:  J Am Heart Assoc       Date:  2019-06-27       Impact factor: 5.501

5.  Neurological complications after cardiac surgery: anesthetic considerations based on outcome evidence.

Authors:  Yong Liu; Kun Chen; Wei Mei
Journal:  Curr Opin Anaesthesiol       Date:  2019-10       Impact factor: 2.706

6.  Current Neurologic Assessment and Neuroprotective Strategies in Cardiac Anesthesia: A Survey to the Membership of the Society of Cardiovascular Anesthesiologists.

Authors:  Martin Krause; Joseph E Morabito; G Burkhard Mackensen; Tjörvi E Perry; Karsten Bartels
Journal:  Anesth Analg       Date:  2020-08       Impact factor: 6.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.